Low Level Laser Therapy and Interferential Current in Osteoarthritis
NCT ID: NCT02898025
Last Updated: 2017-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
168 participants
INTERVENTIONAL
2015-11-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
G1 (Active IFC and Active Laser)
42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. This group (G1) will receive the treatment of Active Interferential Current and Active Laser for 12 sessions.
Active Interferential Current
Involves the application of medium frequency alternating currents
Active Laser
Involves the application of low level laser over the knee
G2 (Active IFC and Placebo Laser)
42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. This group (G2) will receive the treatment of Active Interferential Current and Placebo Laser for 12 sessions.
Active Interferential Current
Involves the application of medium frequency alternating currents
Placebo Laser
It is a sham laser therapy
G3 (Placebo IFC and Active Laser)
42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. This group (G3) will receive Placebo Interferential Current and Active Laser for 12 sessions.
Active Laser
Involves the application of low level laser over the knee
Placebo Interferential Current
It is a sham interferential therapy
G4 (Placebo IFC and Placebo Laser)
42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. The placebo group (G4) will receive Placebo Interferential Current and Placebo Laser for 12 sessions.
Placebo Interferential Current
It is a sham interferential therapy
Placebo Laser
It is a sham laser therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Interferential Current
Involves the application of medium frequency alternating currents
Active Laser
Involves the application of low level laser over the knee
Placebo Interferential Current
It is a sham interferential therapy
Placebo Laser
It is a sham laser therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Radiographic evidence of grade 2 or 3 osteoarthritis based on the Kellgren and Lawrence radiographic entry criteria
* Patients with knee osteoarthritis (s) according to the ACR criteria
* VAS 3 to 8
* 5 to 12 Lequesne
* No complaint of pain in other joints of the lower limbs
* Without neurological and cognitive disorders
* No loss of sensation in the lower limbs
* No surgery on the knee (s) in the last 6 months
* Pain symptoms for at least 6 months
* No infiltrations (s) knee (s) in the last 4 weeks
* No use of analgesics 4 hours before treatment
Exclusion Criteria
* Complaints from other diseases of the lower limbs, knee prosthesis and / or hip joint instabilities and / or surgery in lower limbs, heart disease, uncontrolled hypertension and diabetes, coagulation disorders in anticoagulant therapy, pregnant women, fibromyalgia and individuals who can not perform isokinetic test who have difficulty performing the TUG, and those that are experiencing abnormal sensitivity to algometry
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Cidade de Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Eloin Liebano
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard E Liebano, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Cidade de Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNICID
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alqualo-Costa R, Thome GR, Perracini MR, Liebano RE. Low-level laser therapy and interferential current in patients with knee osteoarthritis: a randomized controlled trial protocol. Pain Manag. 2018 May;8(3):157-166. doi: 10.2217/pmt-2017-0057. Epub 2018 May 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RLiebano
Identifier Type: -
Identifier Source: org_study_id